Tradestie Institutional Equity Comparison Engine
PROK vs EVMN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EVMN Overall Edge
EVMN Captures Institutional Edge (2โ1 Pillars ยท 3โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Evommune, Inc. (EVMN) driven by superior Growth & Margin, Options & Structure while PROK counters with relative strength in Momentum & Technical. Fundamentally, PROK trades at N/M Forward P/E with -24871.4% operating margin (-19.8% YoY revenue) versus EVMN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, PROK sits in BREAKDOWN (51st %ile IV; Dealer Gamma Walls on Pro) against EVMN sits in SURGE (53rd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
PROK N/M vs EVMN N/M Fwd P/E
Growth & Margin Winner
EVMN
Op Margin -24871.4% vs 0.0% ยท YoY -19.8% vs +0.0%
Momentum & Technical Winner
PROK
1Y -54.4% vs -61.0% ยท 52W Pos 10% vs 8%
Options & Structure Winner
EVMN
BREAKDOWN (51st %ile IV) vs SURGE (53rd %ile IV)
PROK
NASDAQ
ProKidney Corp. Class A Ordinary Shares
Biological Products, (No Disgnostic Substances)
$1.04
-0.48% 1D
Market Cap
$417.2M
1M Return
-21.8%
1Y Return
-54.39%
Forward P/E
N/M
Unified AI Score
54.0 / 100
HOLD
Tech 33.0
Fund 65.0
Flow 68.0
Mom 60.0
EVMN
US Equity
Evommune, Inc.
Pharmaceutical Preparations
$7.10
-6.95% 1D
Market Cap
$315.5M
1M Return
+37.33%
1Y Return
-61.03%
Forward P/E
N/M
Unified AI Score
30.0 / 100
SELL
Tech 50.0
Fund 35.0
Flow 69.0
Mom 44.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PROK -54.39%
EVMN -61.03%
Spread: +6.64 pp (PROK Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | PROK Revenue | EVMN Revenue | PROK Op. Margin | EVMN Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2024 | $0M | $10M | -241678.9% | -1000.2% | EVMN |
| FY2025 | $0M | $10M | -18477.8% | -623.6% | EVMN |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PROK | EVMN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $417.2M | $315.5M | Larger Scale | PROK |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -19.8% | +0.0% | Higher Growth | EVMN |
| Operating Margin (TTM) Profitability | -24871.4% | 0.0% | Higher Margin | EVMN |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -73.4% | -69.5% | Higher ROE | EVMN |
| 52-Week Range Position Momentum | 10% ($1โ$3) | 8% ($5โ$33) | Stronger Trend | PROK |
| Beta / 30D Volatility Risk Regime | 1.68ฮฒ ยท 92% Vol | 1.05ฮฒ ยท 118% Vol | Lower Realized Risk | PROK |
| Unified Institutional Score Composite Signal | 54.0 / 100 (HOLD) | 30.0 / 100 (SELL) | Higher Composite | PROK |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PROK vs EVMN Buy Guide
PROK
BREAKDOWN
50d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
51st %ile
IV Regime
Balanced (25thโ60th %ile)
EVMN
SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
53rd %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PROK nor EVMN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.